These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime]. Le Noc P; Bryskier A; Le Noc D Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396 [TBL] [Abstract][Full Text] [Related]
3. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)]. Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385 [TBL] [Abstract][Full Text] [Related]
4. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime]. Rouhan D; Le Noc P; Le Noc D Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone. Bartmann K; Tarbuc R Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518 [TBL] [Abstract][Full Text] [Related]
7. Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin. Okonogi K; Kuno M; Kida M; Mitsuhashi S Antimicrob Agents Chemother; 1981 Aug; 20(2):171-5. PubMed ID: 6269488 [TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study]. Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397 [TBL] [Abstract][Full Text] [Related]
9. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria]. Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime. Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406 [TBL] [Abstract][Full Text] [Related]
11. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams]. Reynaud A; Desnoes M; Derriennic M; Courtieu AL Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216 [TBL] [Abstract][Full Text] [Related]
12. [In vitro antibacterial effect of a new oral cephalosporin, cefixime. Results of a multicenter study]. Soussy CJ; Kitzis MD; Thabaut A; Chanal M; Bure A; Vergnaud M; Reynaud AE; Coulet M; Dabernat H; Muller-Serieys C Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):528-33. PubMed ID: 2508039 [TBL] [Abstract][Full Text] [Related]
13. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)]. Deforges L; Le Van Thoi J; Soussy CJ; Duval J Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282 [TBL] [Abstract][Full Text] [Related]
14. Cefmenoxime: in vitro activity. Stamm JM Am J Med; 1984 Dec; 77(6A):1-3. PubMed ID: 6097114 [TBL] [Abstract][Full Text] [Related]
15. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins]. Baumgärtner M; Dickgiesser N; Müller S; Wundt W Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity and beta-lactamase stability of cefmenoxime. Neu HC; Labthavikul P Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427 [TBL] [Abstract][Full Text] [Related]
17. Comparative activity of ceftizoxime against aminoglycoside-resistant aerobic gram-negative bacilli. Gómez-Lus R; Rubio MC; García C; Gómez-Lus ML; Alejandre MC Drugs Exp Clin Res; 1987; 13(3):155-9. PubMed ID: 3497792 [TBL] [Abstract][Full Text] [Related]
18. Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria. Fuchs PC; Jones RN; Thornsberry C; Barry AL; Gerlach EH; Sommers HM Antimicrob Agents Chemother; 1981 Dec; 20(6):747-59. PubMed ID: 6275784 [TBL] [Abstract][Full Text] [Related]
19. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams]. Jarlier V; Bismuth R; Grosset J Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393 [TBL] [Abstract][Full Text] [Related]
20. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime]. Le Noc P; Bryskier A; Le Noc D Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]